Durvalumab vs Metoprolol

Durvalumab vs Metoprolol: Overview

This comparison examines the pharmacological differences between Durvalumab and Metoprolol.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Metoprolol: Selective beta-1 adrenergic receptor blocker.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Metoprolol — 3-7 hours.

Chemical Properties

Molecular Formula: Metoprolol — C15H25NO3.

Molecular Weight: Metoprolol — 267.3640 g/mol.

Type: Durvalumab — Antibody; Metoprolol — Small molecule.